Revisiting Autoimmunity in Chronic Lymphocytic Leukemia: Prognostic Value of Positive Direct Antiglobulin Test in a Retrospective Study and Literature Review

References

• Rebecca S, Siegel M, Kimberly D, Miller M, Ahmedin Jemal D. Cancer statistics. CA Cancer J Clin. 2017;67(27):7–30.
   Google Scholar
• Hodgson K, Ferrer G, Montserrat E, Moreno C. Chronic lymphocytic leukemia and autoimmunity: a systematic review. Haematologica. 2011;96(5):752–761. doi:10.3324/haematol.2010.036152
   PubMed Web of Science ®Google Scholar
• Fattizzo B, Barcellini W. Autoimmune cytopenias in chronic lymphocytic leukemia: focus on molecular aspects. Front Oncol. 2020;9:1435. doi:10.3389/fonc.2019.01435
   PubMed Web of Science ®Google Scholar
• D’Arena G, Simeon V, D’Auria F, et al. Regulatory T-cells in chronic lymphocytic leukemia: actor or innocent bystander? Am J Blood Res. 2013;3(1):52–57.
   PubMedGoogle Scholar
• Lad DP, Varma S, Varma N, Sachdeva MUS, Bose P, Malhotra P. Regulatory T-cell and T-helper 17 balance in chronic lymphocytic leukemia progression and autoimmune cytopenias. Leuk Lymphoma. 2015;56(8):2424–2428. doi:10.3109/10428194.2014.986479
   PubMed Web of Science ®Google Scholar
• Zent CS, Kay NE. Autoimmune complications in chronic lymphocytic leukaemia (CLL). Best Pract Res Clin Haematol. 2010;23(1):47–59. doi:10.1016/j.beha.2010.01.004
   PubMed Web of Science ®Google Scholar
• Borthakur G, O’Brien S, Wierda WG, et al. Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab–incidence and predictors. Br J Haematol. 2007;136(6):800–805. doi:10.1111/j.1365-2141.2007.06513.x
   PubMed Web of Science ®Google Scholar
• Quinquenel A, Al Nawakil C, Baran‐Marszak F, et al. Old DAT and new data: positive direct antiglobulin test identifies a subgroup with poor outcome among chronic lymphocytic leukemia stage A patients. Am J Hematol. 2015;90(1):E5–E8. doi:10.1002/ajh.23861
   PubMed Web of Science ®Google Scholar
• Barcellini W, Capalbo S, Agostinelli RM, et al. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia. Haematologica. 2006;91(12):1689–1692.
   PubMed Web of Science ®Google Scholar
• Moreno C, Hodgson K, Ferrer G, et al. Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance. Blood. 2010;116(23):4771–4776.
   PubMed Web of Science ®Google Scholar
• Zanotti R, Frattini F, Ghia P, et al. ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients. Am J Hematol. 2010;85(7):494–498. doi:10.1002/ajh.21737
   PubMed Web of Science ®Google Scholar
• Dearden C, Wade R, Else M, et al. The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. Blood. 2008;111(4):1820–1826.
   PubMed Web of Science ®Google Scholar
• Abbas SA, Zeeshan R, Sultan S, Irfan S. Direct Coombs test positivity in B-chronic lymphoid leukemia: a marker of advanced clinical disease. Asian Pac J Cancer Prev. 2015;16(14):6007–6010. doi:10.7314/apjcp.2015.16.14.6007
   PubMedGoogle Scholar
• Ricci F, Tedeschi A, Vismara E, et al. Should a positive direct antiglobulin test be considered a prognostic predictor in chronic lymphocytic leukemia? Clin Lymphoma Myeloma Leuk. 2013;13(4):441–446. doi:10.1016/j.clml.2013.02.024
   Web of Science ®Google Scholar
• Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111(12):5446–5456. doi:10.1182/blood-2007-06-093906
   PubMed Web of Science ®Google Scholar
• Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46(2):219–234. doi:10.1182/blood.V46.2.219.219
   PubMed Web of Science ®Google Scholar
• Hallek M, Cheson BD, Catovsky D, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018;131(25):2745–2760. doi:10.1182/blood-2017-09-806398
   PubMed Web of Science ®Google Scholar
• Xu W, Li J-Y, Miao K-R, et al. The negative prognostic significance of positive direct antiglobulin test in Chinese patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2009;50(9):1482–1487. doi:10.1080/10428190903111930
   PubMed Web of Science ®Google Scholar
• Hamblin TJ, Oscier DG, Young BJ. Autoimmunity in chronic lymphocytic leukaemia. J Clin Pathol. 1986;39(7):713–716. doi:10.1136/jcp.39.7.713
   Web of Science ®Google Scholar
• Mauro FR, Foa R, Cerretti R, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood. 2000;95(9):2786–2792. doi:10.1182/blood.V95.9.2786.009k30_2786_2792
   PubMed Web of Science ®Google Scholar
• Kyasa MJ, Parrish RS, Schichman SA, Zent CS. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol. 2003;74(1):1–8. doi:10.1002/ajh.10369
   PubMed Web of Science ®Google Scholar
• Ricci F, Tedeschi A, Vismara E, et al. Positive Direct Antiglobulin Test (DAT) in Chronic Lymphocytic Leukemia (CLL) Patients: Correlation with Prognostic Factors. American Society of Hematology; 2009.
   Google Scholar
• Shvidel L, Tadmor T, Braester A, et al. Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1518 cases. Ann Hematol. 2013;92(5):661–667. doi:10.1007/s00277-012-1663-3
   PubMed Web of Science ®Google Scholar
• Zent CS, Ding W, Schwager SM, et al. The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma. Br J Haematol. 2008;141(5):615–621. doi:10.1111/j.1365-2141.2008.07086.x
   PubMed Web of Science ®Google Scholar
• Atef B, Azmy E, Aladle D, Mabed M. The prevalence and prognostic significance of autoimmune cytopenias in a cohort of Egyptian patients with chronic lymphocytic leukemia. Hematol Oncol Stem Cell Ther. 2019;12(2):97–104. doi:10.1016/j.hemonc.2019.01.004
   Google Scholar
• Amir E, Seruga B, Kwong R, Tannock IF, Ocaña A. Poor correlation between progression-free and overall survival in modern clinical trials: are composite endpoints the answer? Eur J Cancer. 2012;48(3):385–388. doi:10.1016/j.ejca.2011.10.028
   Web of Science ®Google Scholar
• Binet JL, Leporrier M, Dighiero G, et al. A clinical staging system for chronic lymphocytic leukemia: prognostic significance. Cancer. 1977;40(2):855–864. doi:10.1002/1097-0142(197708)40:2<855::AID-CNCR2820400239>3.0.CO;2-1
   Web of Science ®Google Scholar
• Demir C, Ekinci Ö. Clinical and serological autoimmune complications in chronic lymphocytic leukemia. Wien Klin Wochenschr. 2017;129(15–16):552–557. doi:10.1007/s00508-017-1208-9
   Web of Science ®Google Scholar
• Visentin A, Imbergamo S, Gurrieri C, et al. Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients. Eur J Cancer. 2017;72:103–111. doi:10.1016/j.ejca.2016.11.020
   Web of Science ®Google Scholar
• Duek A, Shvidel L, Braester A, Berrebi A. Clinical and immunologic aspects of B chronic lymphocytic leukemia associated with autoimmune disorders. Isr Med Assoc J. 2006;8(12):828–831.
   PubMed Web of Science ®Google Scholar